Novel disease burden assessment predicts allogeneic transplantation outcomes in myelodysplastic syndrome

Among patients with myelodysplastic syndrome (MDS) undergoing hematopoietic cell transplantation (HCT), the impact of residual pretransplant cytogenetically abnormal cells on outcomes remains uncertain. We analyzed HCT outcomes by time of transplant disease variables, including (1) blast percentage,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Bone Marrow Transplant
Autores principales: Trottier, BJ, Sachs, Z, DeFor, TE, Shune, L, Dolan, M, Weisdorf, DJ, Ustun, C, Warlick, ED
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5319562/
https://ncbi.nlm.nih.gov/pubmed/26595080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2015.274
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares